Insulin biosimilars (Bioton)

胰岛素生物类似药 (Bioton)

Report date: 2022/09/08 16:56:45

Base Information

Drug NameInsulin biosimilars (Bioton)
Drug Alias Name胰岛素生物仿制药 (Bioton)重组人胰岛素生物仿制药 (Bioton)
ClassificationBiologics > Biosimilar
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2013/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBioton Sa
China Registration ClassN/A

Develop Information

Active CompaniesBioton Sa
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A